STOCK TITAN

COSCIENS BIOPHARMA INC (CSCIF) Free Cash Flow by Year

CSCIF

COSCIENS BIOPHARMA INC recorded an outflow of $9.2M in free cash flow in fiscal year 2025. This represents an increase of 41.6% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters COSCIENS BIOPHARMA INC has filed alongside them.

FY2025 annual
Free Cash Flow -$9.2M
YoY +41.6%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CSCIF Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Free Cash Flow-$9.2M+41.6%-$15.7M-376.1%-$3.3M-167.1%$4.9M+157.2%-$8.6MN/AN/A$6.8M+129.7%-$22.9M+21.2%-$29.1M+14.2%-$33.9M

CSCIF Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Free Cash Flow-$1.5M+54.2%-$680K+91.4%-$4.5M-190.8%-$2.5M+15.3%-$3.3M-97.8%-$7.9M-8514.9%-$1.5M-78.3%-$2.9M+27.5%-$1.7M-111.0%$94K+102.4%-$867K+82.3%-$4.1M-177.0%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More COSCIENS BIOPHARMA INC financials

Frequently Asked Questions

What was COSCIENS BIOPHARMA INC's free cash flow in fiscal year 2025?

COSCIENS BIOPHARMA INC recorded an outflow of $9.2M in free cash flow in fiscal year 2025.

How fast is COSCIENS BIOPHARMA INC's free cash flow growing?

COSCIENS BIOPHARMA INC (CSCIF) free cash flow rose by 41.6% year over year, from -$15.7M to -$9.2M in fiscal year 2025.

How has COSCIENS BIOPHARMA INC's free cash flow changed over the years?

Across the 11 fiscal years this page covers, COSCIENS BIOPHARMA INC (CSCIF) free cash flow went from -$33.9M in fiscal year 2015 to -$9.2M in fiscal year 2025.

COSCIENS BIOPHARMA INC (CSCIF) reported -$1.5M in free cash flow in Q4 2025. This represents an increase of 54.2% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what COSCIENS BIOPHARMA INC (CSCIF) reported on that line in every period on record.